Transparency data

Adult reference group

Updated 28 April 2026

© Crown copyright 2026

This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.

Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.

This publication is available at https://www.gov.uk/government/publications/uk-national-screening-committee-register-of-interests/adult-reference-group

This register records declarations made by members in respect of interests they have that are relevant to the remit of the UK NSC’s adult reference group.

Dr Ros Given-Wilson (Chair)

  • interests listed on the UK NSC register

Claire Bailey

  • trustee of Symposium Mammographicum charity

Dr Sunil Bhanot

  • none

Dr Georgia Black

  • works in the Centre for Prevention, Detection and Early Diagnosis, Queen Mary University of London, where many colleagues are involved in research relating to cancer screening programmes

Dr Stephen Bradley

  • NIHR: Co-lead investigator, Methods of Early Detection of Lung cancEr in PrimarY Care (MEDLEY)

  • NIHR: Co-investigator Evaluating the follow-up chest x-ray to detect lung cancer in patients with pneumonia

  • Yorkshire Cancer Research: Co-investigator, Patient-centred models for surveillance and support of cancer survivors with bowel and breast cancer

  • Yorkshire Cancer Research: Co-lead investigator, Improving diagnostic Pathway of patients with Recurrent Urinary tract infections in primary care for early detection of bladder cancer: a feasibility trial (name of the study may change)

  • Cancer Research UK: Funding of doctoral research through CanTest programme grant. Has spoken at events organised by Cancer Research UK and contributed to outputs but has received no direct payments other than travel expenses

Professor Yan Chen

  • research funding via University of Nottingham received from:
    • NHS England
    • Hologic Inc 
    • Lunit Inc
    • Medical Research Council 
    • Public Health Scotland 
    • Public Health Agency in Northern Ireland
    • National Institute for Health and Care Research 
    • EU Horizon 2020 
    • Innovate UK
    • Western Sydney University
  • University of Nottingham one-off honoraria for reviewing grant application from:
    • Region Syddanmark
    • The Research Council in Norway 
    • Swiss Cancer Research

  • CEO of University of Nottingham Spin-out company

  • Unpaid member of: 
    • Radiological Society of North America (RSNA) advisory boards
    • Royal College of Radiologists AI committee
    • European Commission Initiative On Breast Cancer Expert Pool
  • Unpaid collaboration as a follow-up from the RSNA Screening Mammography Breast Cancer Detection AI Challenge with:
    • Lunit
    • Screenpoint Medical
    • iCAD
    • Therapixel

Heidi Douglas

  • interests listed on the UK NSC register

Professor Gareth Evans

  • AstraZeneca (consultancy fee: genetic testing for PARPi treatment) and Springworks (consultancy fee: drug treatment trial advice)
  • registrable shareholding: Tesco and M&S
  • Syantra: advisory role for blood test to detect breast cancer

Professor Allan Hacksaw

  • investigator for SUMMIT lung cancer screening study sponsored by UCL and funded by GRAIL
  • received honorarium for advisory board meeting for GRAIL in 2018
  • received consulting fee from Evidera Inc for a GRAIL-initiated project in 2020
  • unpaid collaboration on joint academic projects with GRAIL
  • unpaid member of MCDs advisory boards for Roche, Adela Bio and Luventix

Professor Steve Halligan

  • none

John Hitchman (PPV)

  • none

Christopher Hughes

  • none

Rebecca Maclean

  • none

Leigh Jackson

  • Medical Research Council: funding to investigate the scientific and ethical issues in genomic newborn screening

  • Prostate Cancer UK: funding to generate new evidence to promote equity in prostate cancer genetic screening

Dr Jim McMorran

  • participation in GRAIL Primary Care Advisory Group

Professor Sarah Pinder

  • Advisory Boards, Honoraria for educational events from Exact Science, Roche and AstraZeneca
  • Member of:
    • National Coordinating Committee for Breast Pathology (Chair) (Royal College of Pathologists and NHS BSP)
    • Sloane Project Steering Committee
    • UK Interdisciplinary Breast Cancer Symposium
    • OPTIMA Trials Management Group
    • MAMMO50 Trial Management Groups
    • Low risk DCIS trial (LORIS) Clinical Trial Management Group
    • NOSTRA Clinical Trial Management Group
    • SMALL Clinical Trial Management Group
    • EndoNET Clinical Trial Management Group
    • various breast pathology groups, including Association of Breast Pathology (Vice-President)
  • via King’s College London, grant funding is received from:
    • Cancer Research UK
    • National Institute for Health Research
    • Wellcome Leap Inc
    • Medical Research Council
  • undertaking research with Paige AI and have undertaken research in the past with Panakeia Technologies (no financial interest with either)

Margaret Powell (PPV)

  • none

Dr Katie Robb

  • none

Professor Alicja Rudnicka

  • none

Nisha Sharma

  • none

Dr Chris Stinton

  • employed by the University of Warwick, which is an approved supplier of reviews for the UK NSC

Lynda Williams

  • chair and trustee of registered charity SWS Cymru (Support With Scoliosis)

Professor Allan Wilson

  • past president of the Institute of Biomedical Science

  • executive member of the British Association for Cytopathology

Dr Stuart Wright

  • co-applicant on a research grant funded by Cancer Research UK: A Case Control Study of women aged 30-39 to augment breast cancer risk prediction and assess acceptability and preference of a systematic risk prediction approach through primary care (BCAN-RAY)
Back to top